“TrialMasterTM’s flexibility and OmniComm’s customer
service were key factors in the selection process. We look forward to a long and
continued relationship going forward.”
Annetine Gelijns, Co-Director of InChoir, Columbia University
“We have enjoyed a very successful relationship with OmniComm Systems for
many years now. They bring to the table a first class EDC product, attention to
detail and responsiveness to our needs. This is particularly important during the
implementation process when timelines are tight. We have found them to be an ideal
business partner.”
Tony Lamas, M.D., Director of Cardiovascular Research and Academic Affairs
Mount Sinai Medical Center and Principal Investigator, TACT and PACT Studies, National
Heart Lung & Blood Institute (NHLBI)
“Optimer has enjoyed a truly supportive relationship with OmniComm and has
been very impressed with both their product and services.”
Michael N. Chang, Ph.D., President and CEO, Optimer
“Having worked with OmniComm and TrialMaster in the past, we knew they were
the perfect match to satisfy our client's high level expectations. These trials
are very sophisticated with complex design requirements that go far beyond your
standard EDC implementation. OmniComm's trial build process and expertise allowed
for a positive, iterative approach that produced the results our Sponsor was hoping
for.”
Lloyd Baroody, CEO, Target Research Associates
“It is important for us to use a full service EDC provider whose capabilities
include both a strong technology product and support services that would compliment
our own efforts.”
Phillip Simmons, Director of Data Management and Biostatistics,
Kos Pharmaceuticals
“After looking at many EDC vendors we selected OmniComm's TrialMaster because
of its flexibility, ease of use and rapid trial development time.”
Wim Makel, Managing Director, CRF-I
“APEX, a well-known, fast growing contract research organization based in
Asia, selected OmniComm’s TrialMaster suite of EDC products after conducting
an extensive evaluation of existing EDC products. “We concluded that TrialMaster
offered the features, flexibility and price required by our company for deployment
as our in-house standard.”
Albert Liou, CEO and Chairman, APEX International
“Asthmatx requires complete and accurate collection of clinical research data
and the ability to analyze the data in the shortest time possible after a database
“freeze” or lock. The capabilities of OmniComm’s’ EDC solution
promises to save Asthmatx time and money. We selected the TrialMaster solution because
of its ease of use and flexible structure. The integrated platform should enable
Asthmatx to save valuable time and provide control over critical trial processes.”
Glendon E. French, President and CEO, Asthmatx
"We are pleased to be partnering with OmniComm, a company that has demonstrated
its experience and ability in delivering comprehensive clinical data solutions on
a global basis. Use of the TrialMaster system has allowed us to build a robust data
management and safety review process and we are confident that TrialMaster will
continue to enhance our efficiency in the drug discovery process."
Erik Henricson, MPH, CINRG Researcher and Coordinator of the Network
“Historically the use of EDC for Phase I studies has been relatively low primarily
because of the very issues OmniComm’s TrialMaster Ph. I is now able to address
which include rapid set-up time, easy to customize platform, smooth integration
with laboratory and other external data and low cost. Since Catalyst is a rapidly
growing full service CRO, we rely on technology driven products like TrialMaster
Ph. I to enable us to perform more studies, faster with greater data quality compared
to traditional methods all at a lower cost to our sponsors.”
Richard Anthony, Ph.D., Chairman and CEO, Catalyst
“OXiGENE has enjoyed a truly supportive relationship with OmniComm and has
been very impressed with both their product and services.”
Scott Young, Chief Operating Officer, OXiGENE
Top
|
